Our client asked:
Our client was interested in assessing the technical and commercial potential of novel biomanufacturing technologies to provide more sustainable sources of next generation biomaterials for their products in the future.
The project story:
- Sagentia Innovation investigated which existing or nascent biomanufacturing approaches have potential for large-scale, commercially viable biomaterials production in 10-20 years and assessed what are the main challenges that remain to be addressed
- Each solution was evaluated for its potential to enable cost-effective, sustainable and large-scale biomaterials production
- Solutions were assessed to consider how they address key challenges and to evaluate their relative strengths
- The IP of biomanufacturing technologies from prioritised organisations was assessed and complimented by a review of relevant consortia and funding initiatives that are relevant to biomaterials, to identify commercial opportunitiesInsights and conclusions were validated and enriched through interviews with key opinion leaders in the field
Client benefit:
Sagentia Innovation delivered a report summarizing key insights into biomanufacturing, including technology maturity, common challenges, and strategic recommendations to support the client’s product portfolio
Our analysis helped the client understand key IP holders and the broader biomanufacturing ecosystem, including funding, consortia activity, and academic partnerships.
Consumer markets
Discover the expertise we offer across the consumer market and how we collaborate to solve challenges through R&D.
Innovation services
Join our dynamic consultancy business and thrive in an exciting science and technology environment that collaborate with leading global organisations.
Contact
We’d be delighted to discuss your challenges and explore how innovative thinking could help solve them. If you’d like us to get in touch, please complete the contact us form.